<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the
Securities Exchange Act of 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):
February 17, 1998
CARACO PHARMACEUTICAL LABORATORIES, LTD.
------------------------------------------------
EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER
Michigan 0-24676 38-25-5723
---------------------------- ------------------- -------------------
(STATE OR OTHER JURISDICTION COMMISSION FILE NO. IRS EMPLOYER ID NO.
OF INCORPORATION)
1150 Elijah McCoy Drive, Detroit, MI 48202
-------------------------------------------
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
REGISTRANT'S TELEPHONE NO.: (313) 871-8400
The Exhibit Index is located on page 3.
The total number of pages is 4.
<PAGE> 2
ITEM 5. OTHER EVENTS.
On February 17, 1998 Caraco Pharmaceutical Laboratories Ltd. announced
the resignation of its Chief Financial Officer. Additional details are set
forth on the attached public announcement (EXHIBIT A).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Company has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
CARACO PHARMACEUTICAL LABORATORIES, LTD.
/s/ Narendra N. Borkar
-----------------------------------------
Narendra N. Borkar
Chief Executive Officer
(A duly authorized signatory
of the Company)
DATED: February 17, 1998
<PAGE> 3
EXHIBIT INDEX
Exhibit Table
Number Exhibit Page
- ----------------------------------------------------------------------------
99 EXHIBIT A - Company's Press Release 4
dated February 17, 1998
<PAGE> 1
EXHIBIT A
Caraco Announces Management Change
DETROIT, Feb. 17 /PRNewswire/ -- Caraco Pharmaceutical Laboratories,
Ltd. today announced that effective as of February 28, 1998, its CFO Allan
Hammer will be leaving the company to pursue other interests. Mr. Hammer was
Caraco's Chief Financial Officer, Treasurer, and Corporate Secretary from 1994
and was responsible for financial management of this company during its
critical phases including the recent alliance with Sun Pharmaceuticals.
Sun is a vertically integrated Indian Pharmaceutical Company that went
public in October 1994. Its extensive product base includes significant
presence in the therapeutic areas of neurology, psychiatry, cardiology,
gastroenterology, oncology and anti-infectives.
Caraco Pharmaceutical Laboratories Ltd., is engaged in the development,
manufacture and marketing of generic pharmaceuticals for the ethical and over
the counter markets.
SOURCE Caraco Pharmaceutical Laboratories Ltd.
-0- 02/17/98
/CONTACT: Narendra Borkar of Caraco, 313-871-8400/
(CARA)
